A bill to expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.
(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)
Adding Zika Virus to the FDA Priority Review Voucher Program Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)
The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.
Referred to the Subcommittee on Health.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S1606-1607; text as passed Senate: CR S1606)
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S1606-1607; text as passed Senate: CR S1606)
Message on Senate action sent to the House.
Received in the House.
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Mrs. Brooks (IN) moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1602-1605)
DEBATE - The House proceeded with forty minutes of debate on S. 2512.
Enacted as Public Law 114-146
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1602)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1602)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 114-146.
Became Public Law No: 114-146.